Owkin

Owkin is a TechBio company that combines the best of human and artificial intelligence (AI) to ensure every patient gets the right treatment. By understanding complex biology through AI, it identifies new treatments, de-risks and accelerates clinical trials and develops AI diagnostics. Owkin uses privacy-enhancing federation to access up-to- date multimodal patient data that unlocks AI's potential to power precision medicine. It merges wet lab experiments with advanced AI techniques to create a feedback loop for accelerated discovery and innovation. Owkin founded MOSAIC, a multi-omics atlas for cancer research. Owkin has raised $300 million through investments from leading biopharma companies and venture funds.